Connor, Clark & Lunn Investment Management Ltd. Procept Bio Robotics Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 49,126 shares of PRCT stock, worth $2.85 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
49,126
Previous 17,111
187.1%
Holding current value
$2.85 Million
Previous $1.37 Million
188.69%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$299 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$203 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$102 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$86.6 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$70.1 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.59B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...